Study on Immunogenicity, Reactogenicity and Safety of the VAC Δ6 Vaccine in Volunteers Aged 18-60 Years
Conditions: Smallpox; Monkeypox; Cowpox; Vaccinia Virus Infection Interventions: Biological: VAC∆6 vaccine (10⁷ PFU); Biological: VAC∆6 vaccine (10⁶ PFU); Biological: Live Smallpox Vaccine; Other: Placebo (Sodium chloride bufus, 0.9%) Sponsor: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology " Vector " Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Safety and Tolerability Study of the VAC ∆6 Vaccine in Volunteers Aged 18-40 Years
Conditions: Smallpox; Monkeypox; Cowpox; Vaccinia Virus Infection Interventions: Biological: VAC∆6 vaccine - оnce at a dose of 10⁶ PFU; Biological: VAC∆6 vaccine - once at a dose of 10⁷ PFU; Biological: VAC∆6 vaccine - twice at a dose of 10⁶ PFU; Biological: Live smallpox vaccine (Smallpox vaccine) + The OspaVir® inactivated smallpox vaccine Sponsor: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology " Vector " Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials
